SEC Form 4 · accession 0000903423-18-000564
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
GLAXOSMITHKLINE PLC
Other
Period of report
Oct 16, 2018
Accepted (ET)
Oct 18, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 16, 2018 | S | 7,343,492 | $11.69 | D | 0 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of Common Stock were held of record by Glaxo Group Limited, which is an indirect wholly-owned subsidiary of Reporting Person.